A. Süner Et Al. , "Effectiveness and safety of cabazitaxel chemotherapy for metastatic castration-resistant prostatic carcinoma on Turkish patients (The Anatolian Society of Medical Oncology).," European review for medical and pharmacological sciences , vol.20, pp.1238-43, 2016
Süner, A. Et Al. 2016. Effectiveness and safety of cabazitaxel chemotherapy for metastatic castration-resistant prostatic carcinoma on Turkish patients (The Anatolian Society of Medical Oncology).. European review for medical and pharmacological sciences , vol.20 , 1238-43.
Süner, A., Aydın, D., Hacıoğlu, M., Doğu, G., İmamoğlu, G., Menekşe, S., ... Pilancı, K.(2016). Effectiveness and safety of cabazitaxel chemotherapy for metastatic castration-resistant prostatic carcinoma on Turkish patients (The Anatolian Society of Medical Oncology).. European review for medical and pharmacological sciences , vol.20, 1238-43.
Süner, A Et Al. "Effectiveness and safety of cabazitaxel chemotherapy for metastatic castration-resistant prostatic carcinoma on Turkish patients (The Anatolian Society of Medical Oncology).," European review for medical and pharmacological sciences , vol.20, 1238-43, 2016
Süner, A Et Al. "Effectiveness and safety of cabazitaxel chemotherapy for metastatic castration-resistant prostatic carcinoma on Turkish patients (The Anatolian Society of Medical Oncology).." European review for medical and pharmacological sciences , vol.20, pp.1238-43, 2016
Süner, A. Et Al. (2016) . "Effectiveness and safety of cabazitaxel chemotherapy for metastatic castration-resistant prostatic carcinoma on Turkish patients (The Anatolian Society of Medical Oncology).." European review for medical and pharmacological sciences , vol.20, pp.1238-43.
@article{article, author={A Süner Et Al. }, title={Effectiveness and safety of cabazitaxel chemotherapy for metastatic castration-resistant prostatic carcinoma on Turkish patients (The Anatolian Society of Medical Oncology).}, journal={European review for medical and pharmacological sciences}, year=2016, pages={1238-43} }